The chances of beating aggressive breast cancer were raised for women who had "killer" T-cells near their tumour, a study has found.
The killer T-cells destroy cancerous cells by blasting them with toxic proteins and patients found to have them were 10% more likely to live for five years or more than a breast cancer sufferer without them.
The association was seen in women with non-hormone sensitive breast cancer and cancers marked by especially active HER2 genes.
Lead researcher Dr Raza Ali, a lecturer at the Cancer Research UK Cambridge Institute, explained: "This important insight could help doctors personalise a woman's treatment based on her immunological profile and also suggests new treatments should harness the immune system to fight cancer."
More top news
Parliamentary inquiry into the retailer's role in BHS's failure is a damning indictment of an entrepreneur who was trumpeted over the years.
Damning parliamentary inquiry accuses the retail magnate of seeking to blame anyone but himself for the collapse of BHS.
The cyclist said the victory was as sweet as his first win as he became the first Briton to win the race three times.